Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002369545 | SCV002664100 | pathogenic | Hereditary cancer-predisposing syndrome | 2022-06-23 | criteria provided, single submitter | clinical testing | The c.681_689delAAAAAAAGCinsGAAAAAGG pathogenic mutation, located in coding exon 4 of the MSH2 gene, results from the deletion of 9 nucleotides and insertion of 8 nucleotides causing a translational frameshift with a predicted alternate stop codon (p.A230Vfs*16). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. |